Documentation
Categories
< All Topics
Print

International Conference for Harmonization

Updated

International Conference for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) is a global organization that aims to harmonize the regulatory requirements for the development, registration, and post-approval of pharmaceutical products. ICH was established in 1990 by regulatory authorities and the pharmaceutical industry from Europe, Japan, and the United States.

ICH’s goal is to improve the efficiency and effectiveness of the development, registration, and post-approval of pharmaceutical products, while ensuring the safety and efficacy of these products for patients. To achieve this goal, ICH develops and promotes the harmonization of regulatory guidelines, standards, and practices for the development and registration of pharmaceutical products.

Some of the key areas of focus for ICH include:

  1. Clinical trial design and conduct: ICH provides guidance on the design and conduct of clinical trials to ensure that the results of these trials are scientifically valid and relevant to the patient population being studied.
  2. Quality of pharmaceutical products: ICH provides guidance on the quality of pharmaceutical products to ensure that these products meet the necessary standards for safety, efficacy, and quality.
  3. Safety of pharmaceutical products: ICH provides guidance on the safety of pharmaceutical products, including the assessment of the potential risks and benefits of these products, and the measures that should be taken to minimize the risks to patients.
  4. Environmental risk assessment: ICH provides guidance on the environmental risk assessment of pharmaceutical products, including the potential impact of these products on the environment.

The ICH guidelines are widely adopted by regulatory authorities and the pharmaceutical industry globally and are considered the gold standard for the development and registration of pharmaceutical products. ICH continues to play a crucial role in promoting the harmonization of regulatory requirements and ensuring the safety and efficacy of pharmaceutical products for patients.

You may be interested in the programs below: